---
figid: PMC9415417__pharmaceuticals-15-00952-g002
figtitle: Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic
  Kidney Disease
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Nymphalis io
pmcid: PMC9415417
filename: pharmaceuticals-15-00952-g002.jpg
figlink: /pmc/articles/PMC9415417/figure/pharmaceuticals-15-00952-f002/
number: F2
caption: Molecular mechanism of CaMs on osteoclasts in CKD. Osteoblast and osteoclast
  proliferation, differentiation, and apoptosis are influenced by local extracellular
  calcium concentrations. The activation of the RANK/RANKL signal from osteoblasts
  modulates osteoclastogenesis. The signal induces the elevation of endoplasmic reticulum
  stress (ER stress), which activates the cAMP response element-binding protein (CREB)
  phosphorylation. The downstream transcription of the nuclear factor of activated
  T cells, cytoplasmic (NFATc1) activates osteoclastogenesis. On the other hand, ER
  stress also activates the autophagy process to maintain osteoclast viability. RANK/RANKL
  also inhibits osteoclast apoptosis. CaMs induce the release of Wnt-10b from osteoclasts
  and inhibit the autophagy vial, activating the Akt/mTOR pathway. In this manner,
  CaMs increase bone formation, along with the apoptosis of the osteoclast.
papertitle: Role of Calcimimetics in Treating Bone and Mineral Disorders Related to
  Chronic Kidney Disease.
reftext: Yi-Chou Hou, et al. Pharmaceuticals (Basel). 2022 Aug;15(8):952.
year: '2022'
doi: 10.3390/ph15080952
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI
keywords: calcimimetics | calcium-sensing receptors | CKDâ€“MBD | fibroblast growth
  factor 23 | secondary hyperparathyroidism
automl_pathway: 0.9361337
figid_alias: PMC9415417__F2
figtype: Figure
organisms_ner:
- Bos taurus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC9415417__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9415417__pharmaceuticals-15-00952-g002.html
  '@type': Dataset
  description: Molecular mechanism of CaMs on osteoclasts in CKD. Osteoblast and osteoclast
    proliferation, differentiation, and apoptosis are influenced by local extracellular
    calcium concentrations. The activation of the RANK/RANKL signal from osteoblasts
    modulates osteoclastogenesis. The signal induces the elevation of endoplasmic
    reticulum stress (ER stress), which activates the cAMP response element-binding
    protein (CREB) phosphorylation. The downstream transcription of the nuclear factor
    of activated T cells, cytoplasmic (NFATc1) activates osteoclastogenesis. On the
    other hand, ER stress also activates the autophagy process to maintain osteoclast
    viability. RANK/RANKL also inhibits osteoclast apoptosis. CaMs induce the release
    of Wnt-10b from osteoclasts and inhibit the autophagy vial, activating the Akt/mTOR
    pathway. In this manner, CaMs increase bone formation, along with the apoptosis
    of the osteoclast.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASR
  - WNT10B
  - AD
  - BAX
  - AKT1
  - CREB1
  - MTOR
  - NFATC1
  - Tnfsf11
  - Calm1
  - Tmem50a
  - Rrs1
  - Casr
  - Tnfrsf11a
  - Wnt10b
  - Ad
  - Bax
  - Nkx3-1
  - It
  - Akt1
  - Creb1
  - Casp9
  - Mtor
  - Nfatc1
  - Casp3
  - Calm2
  - Wnt2
  - Prkaa2
  - TNFSF11
  - CALM1
  - CALM2
  - CALM3
  - KRIT1
  - CAMKMT
  - TNFRSF11A
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AKT2
  - AKT3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
---
